Cancer Stem Cells Market by Type, Application, and Region – Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2030
Overview
The Cancer Stem Cells Market size was valued at USD 1315.70 Million in 2023 and the total Cancer Stem Cells revenue is expected to grow at a CAGR of 9.40% from 2024 to 2030, reaching nearly USD 2467.63 Million.
The global Cancer Stem Cells market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Cancer Stem Cells report also provides trends by market segments, technology, and investment with a competitive landscape.
To know about the Research Methodology :- Request Free Sample Report
Cancer Stem Cells Market Overview:
Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), are self-renewing cells that can repair themselves. Acute myeloid leukemia, as well as breast and central nervous system tumors, have been shown to contain cancer stem cells. Cancer stem cells can play a unique role in tumor metastasis, and understanding them could lead to the production of predictive and prognostic markers as well as targeted therapeutic interventions. Chemotherapy-resistant cancer stem cells are considered to result in a bad clinical outcome.
Stem cells have been successfully used in immuno-reconstitution and blood replenishment following tumor formation or treatment over the past several years. Furthermore, these cells have attracted a lot of interest from healthcare organizations because they can be used to deliver anti-cancer drugs and regenerate tissue.
According to World Health Organization (WHO) cancer is the first or second leading cause of death before the age of 70 in 112 of 183 countries in 2021, and third or fourth in another 23 countries. The rise of cancer as a leading cause of death is partially due to significant decreases in stroke and coronary heart disease mortality rates in many countries when compared to cancer.
Cancer Stem Cells Market Dynamics:
Drivers:
The rapid acceptance of stem cells by healthcare professionals for tissue regeneration and as methods for anti-cancer drug delivery is propelling the cancer stem cells market forward. The use of stem cells for tumor treatment has been reported to be effective by healthcare professionals all over the world.
Impact of increased public-private investment, public awareness of product therapeutic power, and the creation of a regulatory structure for stem cell therapeutics are fueling market growth while limiting tumor growth.
The requirement for CSC therapy supply has increased as the number of FDA approvals for stem cell therapy has grown. The rising prevalence of chronic diseases, as well as a large number of stem cell beneficiaries, are driving the market ahead.
Restraints:
The high cost of stem cell therapy treatment and stringent international healthcare agency regulations for the use of stem cell therapy, on the other hand, are impeding the development of the cancer stem cells industry.
Cancer Stem Cells Market Segment Analysis:
Based on Type, the Cancer Stem Cell Market is fragmented into sub-segments such as Cell Culturing, Cell Separation, Cell Analysis, and Molecular Analysis. Among them, the Cell Culturing Sub-segment is expected to dominate the market during the forecast period.
Based on Application, the Breast Cancer Diagnosis and treatment sub-segment is expected to grow at the highest pace owing to increased cases of Breast cancer worldwide followed by lung cancer. Every year, it affects 2.1 million people, and according to the WHO, 627,000 women die from it, accounting for roughly 15% of all cancer deaths among women.
Cancer Stem Cells Market Regional Insights:
North America dominated the global cancer stem cell market in 2023. The demand for cancer stem cells in North America is expected to rise at a significant pace in the coming years. The availability of state-of-the-art infrastructure for medical research, the participation of a large number of organizations involved in stem cell therapy research and development as well as advances in medical research, are driving the growth of the cancer stem cells market in the area. The American Government is a significant contributor, with major consulting firms and market vendors based in the country. Multiple pipeline developments in the area are driving up consumer demand.
Cancer stem cells might see rapid growth in the Asia Pacific region, owing to the involvement of many organizations focused on stem cell research and development. Furthermore, funding agencies are offering grants to research groups in Asian countries to help them accelerate their clinical research on cancer stem cells.
Latin America, on the other hand, will rise at a modest pace in the coming years. In the coming years, development in the Middle East and Africa would be slower.
In 2020, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) will be diagnosed worldwide, with almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer). Female breast cancer (2.26 million cases), lung (2.21), and prostate cancer (1.41 million cases) were the most frequently diagnosed cancers worldwide; lung (1.79 million deaths), liver (830000), and stomach cancers were the most common causes of cancer death (769000).
The objective of the report is to present a comprehensive analysis of the global market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the global market dynamics, structure by analyzing the market segments and project the global market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global market make the report investor’s guide.
Cancer Stem Cells Market Key Developments:
Tel Aviv University researchers recently unveiled an innovative biosensor that can kill leukemic cells. The researchers want to reduce the rate of blood cancer relapse by focusing on the most malignant leukemic stem cells. Meanwhile, stem cell research is a rapidly growing medical field in Turkey, which is now known as Europe's "big star in stem cell."
Cancer Stem Cells Market Scope: Inquire before buying
| Cancer Stem Cells Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2023 | Forecast Period: | 2024-2030 |
| Historical Data: | 2018 to 2023 | Market Size in 2023: | USD 1315.70 Mn. |
| Forecast Period 2024 to 2030 CAGR: | 9.40% | Market Size in 2030: | USD 2467.63 Mn. |
| Segments Covered: | by Type | Cell Culturing Cell Separation Cell Analysis Molecular Analysis Others |
|
| by Application | Breast Cancer Diagnosis and Treatment Prostate Cancer Diagnosis and Treatment Colorectal Cancer Diagnosis and Treatment Lung Cancer Diagnosis and Treatment Others |
||
Cancer Stem Cells Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Cancer Stem Cells Market, Key Players
1. Thermo Fisher Scientific, Inc.
2. Abbvie, Inc.
3. Merck KGaA
4. Bionomics
5. Lonza
6. Stemline Therapeutics, Inc.
7. Biotime, Inc.
8. Sino Biological
9. Irvine Scientific
10. Oncomed Pharmaceuticals, Inc.
11. Stemcell Technologies, Inc.
12. Macrogenics, Inc.
13. Miltenyi Biotec
14. Other Key Players
Frequently Asked Questions:
1. Which region has the largest share in Global Cancer Stem Cells Market?
Ans: North America region holds the highest share in 2023.
2. What was the Global Cancer Stem Cells Market size in 2023?
Ans: The Global Cancer Stem Cells Market size was USD 1315.70 Million in 2023.
3. What is scope of the Global Cancer Stem Cells market report?
Ans: Global Cancer Stem Cells Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Cancer Stem Cells market?
Ans: The important key players in the Global Cancer Stem Cells Market are – Thermo Fisher Scientific, Inc., Abbvie, Inc., Merck KGaA, Bionomics, Lonza, Stemline Therapeutics, Inc., Biotime, Inc., Sino Biological, Irvine Scientific, Oncomed Pharmaceuticals, Inc., Stemcell Technologies, Inc., Macrogenics, Inc., Miltenyi Biotec, and Other Key Players.
5. What is the study period of this market?
Ans: The Global Cancer Stem Cells Market is studied from 2023 to 2030.